Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
COHANCE

Cohance Lifesciences Share Price

 

 

Cohance Lifesciences live price: ₹369.2. It opened at ₹388 vs previous close ₹391; intraday high/low: ₹388/₹367. The 50 & 200 DMA stand at ₹347.06/₹589.53.

Cohance Lifesciences Performance

  • Today's Low
  • ₹367
  • Today's High
  • ₹388
  • 52 Week Low
  • ₹267
  • 52 Week High
  • ₹1,250
  • Open Price₹388
  • Previous Close₹391
  • Volume3,207,500
  • 50 DMA₹347.06
  • 100 DMA₹431.93
  • 200 DMA₹589.53

Cohance Lifesciences Chart

Investment Returns

  • Over 1 Month + 23.38%
  • Over 3 Month -11.6%
  • Over 6 Month -58.51%
  • Over 1 Year -68.39%

Smart Investing Starts Here Start SIP with Cohance Lifesciences for Steady Growth!

Invest Now

Cohance Lifesciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 70
  • PEG Ratio
  • -2.5
  • Market Cap Cr
  • 14,124
  • P/B Ratio
  • 3.7
  • Average True Range
  • 20.13
  • EPS
  • 7.86
  • Dividend Yield
  • 0
  • MACD Signal
  • 5.81
  • RSI
  • 62.43
  • MFI
  • 87.46

Cohance Lifesciences Financials

Cohance Lifesciences Technicals

EMA & SMA

Current Price
₹369.20
-21.35 (-5.47%)
pointer
  • Bearish Moving Average 5
  • Bullish Moving Average 11
  • 20 Day
  • ₹334.81
  • 50 Day
  • ₹347.06
  • 100 Day
  • ₹431.93
  • 200 Day
  • ₹589.53

Resistance and Support

374.73 Pivot Speed
  • R3 403.47
  • R2 395.73
  • R1 382.47
  • S1 361.47
  • S2 353.73
  • S3 340.47

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Suven Pharmaceuticals Ltd. is a leading pharmaceutical company specializing in contract development and manufacturing services (CDMO). It focuses on producing intermediates and active pharmaceutical ingredients (APIs), serving global pharmaceutical companies with innovative and high-quality solutions.

Cohance Lifesciences Ltd has an operating revenue of Rs. 2,051.45 Cr. on a trailing 12-month basis. An annual revenue growth of 13% is good, Pre-tax margin of 29% is great, ROE of 15% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 200DMA and around 22% up from its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 20 which is a POOR score indicating inconsistency in earnings, a RS Rating of 3 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 45 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Cohance Lifesciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-12 Quarterly Results
2025-11-12 Quarterly Results
2025-08-13 Quarterly Results
2025-05-28 Audited Results
2025-02-12 Quarterly Results
Date Purpose Remarks
2022-09-12 INTERIM Rs.1.00 per share(100%)Interim Dividend
2022-09-12 SPECIAL Rs.5.00 per share(500%)Special Dividend
2022-05-17 INTERIM Re.1.00 per shaer (100%) Second Interim Dividend
2022-05-17 SPECIAL Rs.1.00 per share(100%)Special Dividend
2022-02-16 INTERIM Rs.1.00 per share(100%)Interim Dividend
View Cohance Lifesciences Dividend History Arrow

Cohance Lifesciences F&O

Cohance Lifesciences Shareholding Pattern

57.49%
17.36%
3.94%
6.01%
0%
6.76%
8.44%

Cohance Lifesciences FAQs

Cohance Lifesciences share price is ₹369 As on 20 April, 2026 | 19:07

The Market Cap of Cohance Lifesciences is ₹14124.4 Cr As on 20 April, 2026 | 19:07

The P/E ratio of Cohance Lifesciences is 70 As on 20 April, 2026 | 19:07

The PB ratio of Cohance Lifesciences is 3.7 As on 20 April, 2026 | 19:07

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23